Published September, 2011
By David Alberts and Earl A. Surwit
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Treatment and Research
Rating:
Availability: Available

High-risk endometrial carcinoma is defined as those patients with moderately differentiated lesions with deep myometrial invasion, poor ly differentiated carcinoma of the endometrium, and the high-risk histolo gies such as papillary carcinoma and clear-cell carcinomas.

---

Published September, 2011
By David M. Goldenberg
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Treatment and Research
Rating:
Availability: Available

It is an attempt to establish a critical mass of oncology literature covering virtually all oncology topics, revised frequently to keep the coverage up to date, and easily available on a single library shelf or by a single personal subscription.

---

Published September, 2011
By Larry Nathanson
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Treatment and Research
Rating:
Availability: Available

It is an attempt to establish a critical mass of oncology literature covering virtually all oncology topics, revised frequently to keep the coverage up to date, easily available on a single library shelf or by a single personal subscription.

---

Published September, 2011
By Paul H. Sugarbaker
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Treatment and Research
Rating:
Availability: Available

How ever, much can be done for these patients - resection of primary cancers, omentectomies to reduce ascites formation, management of recurrent ascites, management of intestinal obstruction, nutritional care, and, hopefully, intraperitoneal chemotherapy.

---

Published September, 2011
By Jerome J. DeCosse and Paul Sherlock
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Treatment and Research
Rating:
Availability: Available

It is an attempt to establish a critical mass of oncology literature covering virtually all oncology topics, revised frequently to keep the coverage up to date, easily available on a single library shelf or by a single personal sub scription.

---

Published September, 2011
By Timothy L. Ratliff and William J. Catalona
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Treatment and Research
Rating:
Availability: Available

It is difficult even for experts in reputed areas of advancement to distinguish true advances from false leads, but it is far more difficult yet for those whose expertise lies in other areas to evaluate important advances.

---

Published September, 2011
By Richard J. Santen and Andrea Manni
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Treatment and Research
Rating:
Availability: Available

Patients with a variety of tumors present to the physician because of clinical manifestations of hormones secreted in excess.

---

Published September, 2011
By Paul H. Sugarbaker
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Treatment and Research
Rating:
Availability: Available

Peritoneal carcinomatosis dominates the clinical picture of many patients with gastrointestinal, gynecological and urological cancers.

---

Published September, 2011
By William N. Hait
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Treatment and Research
Rating:
Availability: Available

Resistance to treatment represents the final common outcome for far too many patients with cancer. In this volume of Drug Resistance, leading investigators in the field have reviewed the most basic mechanisms of drug resistance, and have proposed ways to modulate resistance.

---

Published September, 2011
By J. Klastersky
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Treatment and Research
Rating:
Availability: Available

Despite the major developments in the therapeutic armamentarium for the treatment of infection, the morbidity and mortality of this complication remains very high in patients with compromised defences.

---